ReviewJournal of medical virology2021

SARS-CoV-2 replicating in nonprimate mammalian cells probably have critical advantages for COVID-19 vaccines due to anti-Gal antibodies: A minireview and proposals.

Ji-Ming ChenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.